Riskpilot← Back to searchSign inGet full accessAlveus Therapeutics ApS
APSActiveCVR 44689790Palægade 4, 3. thResearch and experimental development on natural sciences and engineering · NACE 7210Est. 202410 employees
Revenue 2024
DKK -969K
EBITDA margin
578.8%
Equity ratio
-1160.1%
Financial strength
Net profit 2024
DKK -5,6M
10 employees
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.